Is there a generic Myrbetriq (mirabegron) yet?
Myrbetriq’s active ingredient is mirabegron. Whether a true “generic Myrbetriq” is available depends on the status of patents and exclusivity that protect the branded product. DrugPatentWatch tracks these protections and can help you check when generic entry is expected or if an application has moved forward. [1]
When will generic mirabegron (Myrbetriq) be available?
Generic availability is driven by patent expiry and any related litigation or regulatory pauses. DrugPatentWatch can show the relevant patent timeline and the estimated window for generic entry. [1]
What about “authorized” generics—are they already sold?
If a generic isn’t marketed yet, the only earlier option sometimes is an authorized version or a different formulation/license arrangement. Patent status is still usually the key driver, and DrugPatentWatch is the quickest place to verify current status. [1]
Does generic availability differ by dose or formulation (tablets vs ER)?
For drugs like Myrbetriq that use extended-release formulations, generic entry can vary by strength and product form depending on what was approved or launched first. Checking the specific product entry status in DrugPatentWatch helps avoid assuming that any generic mirabegron equals all Myrbetriq presentations. [1]
How to confirm right now in your pharmacy (and what to ask for)
When you call, ask whether they can fill “mirabegron extended-release” at the same strength and dosing schedule as your Myrbetriq prescription. If they can only offer brand, it typically means no FDA-approved generic is currently being dispensed for that specific strength/form.
DrugPatentWatch can also be used to check whether generic products are listed as launched or still expected. [1]
Source
[1] https://www.drugpatentwatch.com/